Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Active, not recruiting1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

active_not_recruiting133%
recruiting133%
unknown133%

Recent Activity

2 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

SPIDER: A Research & QI Collaboration Supporting Practices in Improving Care for Complex Elderly Patients

NCT03689049
recruitingnot_applicable

Suture-Mediated Closure System Following Percutaneous Common Femoral Vein Procedures

NCT07554976
unknownnot_applicable

Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting

NCT04904250

Clinical Trials (3)

Showing 3 of 3 trials
NCT03689049Not Applicable

SPIDER: A Research & QI Collaboration Supporting Practices in Improving Care for Complex Elderly Patients

Active Not Recruiting
NCT07554976Not Applicable

Suture-Mediated Closure System Following Percutaneous Common Femoral Vein Procedures

Recruiting
NCT04904250Not Applicable

Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3